ChiCTR2200065425
正在进行
/
/
/
2022-11-04
/
/
Colorectal cancer
The effectiveness of patient navigator intervention in promoting the uptake of colorectal cancer screening for the average risks older adults in Hong Kong: a pilot study
The effectiveness of patient navigator intervention in promoting the uptake of colorectal cancer screening for the average risks older adults in Hong Kong: a pilot study
Phase 1 1. Develop a training program for lay navigators in facilitating CRC screening uptake. 2. Evaluate the effectiveness of the training program in improving the knowledge of CRC of the lay navigators by completing pretest and posttest related to the CRC knowledge. 3. Evaluate the self-efficacy of lay navigators in providing PN intervention by completing pretest and posttest of self-efficacy scale. 4. Evaluate the satisfaction of the program by the lay navigators after training. Phase 2 1. Develop and implement an evidenced-based PN intervention to enhance the uptake of CRC screening for the average risk of older adults in Hong Kong. 2. Evaluate the feasibility and acceptability of PN intervention by assessing the screening rate, recruitment rate, percentage of eligibility, consent rate, withdrawal rate during recruitment, attrition rate of the participants and satisfaction rate of the participants. 3. Evaluate the preliminary effect of the PN intervention by the uptake rate of the CRC screening of the average risk older adults compared to control arm at baseline and 3 months after the intervention. 4. Determine the preliminary effects of PN intervention on knowledge, perceived susceptibility, severity, benefits and barriers on CRC screening.
随机平行对照
探索性研究/预试验
For the recruited 60 participants, they will be randomly allocated to one of the two arms by using computer-generated randomization scheme: 30 participants will be allocated to an intervention arm that will be given lay navigator intervention. 30 participants will be allocated to wait list control arm.
The participants will be blinded for the allocation of intervention or control group.
Hong Kong Metropolitan University
/
30
/
2022-11-09
2023-06-30
/
Phase 1 1. Older adults aged 50-75 years; 2. Speak fluent Cantonese; 3. Education level up to secondary school to facilitate the delivery of the CRC information; 4. Have experience in CRC screening by using FOBT/FIT; 5. Willing to complete the training programme and act as lay navigator for the target participants. Phase 2 1. Average-risk older adults who age 50 -75 will be recruited as participants in this study; 2. He/She should have no history of CRC, no chronic inflammation of the bowel, no first-degree relatives having CRC and have never screened for CRC.；
请登录查看1. Have mental and cognitive problems; 2. Prior CRC cancer.；
请登录查看Hong Kong Metropolitan University
/
丁香园 Insight 数据库2026-02-28
细胞与基因治疗领域2026-02-28
医药观澜2026-02-28
禾沐基因2026-02-28
金赛药业2026-02-28
生物制药小编2026-02-28
医药笔记2026-02-28
百奥赛图2026-02-28
九洲药业2026-02-28
邴药说2026-02-28
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
